Dongxiao Tang
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
IL-12p40 drives oral squamous cell carcinoma progression via MMPs and IL-12Rβ1/STAT3 signaling.
Journal: Cancer cell international
Published: March 03, 2026
YTHDF2 drives oral squamous cell carcinoma progression via m6A-dependent degradation of MTUS1/ATIP1 mRNA and mitochondrial dysregulation.
Journal: Cellular signalling
Published: July 17, 2025
Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial.
Journal: Cancer communications (London, England)
Published: December 02, 2024
NSUN2 Promotes Head and Neck Squamous Cell Carcinoma Progression by Targeting EMT-Related Gene LAMC2 in an m5C-YBX1-Dependent Manner.
Journal: Biomedicines
Published: August 29, 2024
Mitochondrial outer membrane protein MTUS1/ATIP1 exerts antitumor effects through ROS-induced mitochondrial pyroptosis in head and neck squamous cell carcinoma.
Journal: International journal of biological sciences
Published: January 28, 2024
Squamous papilloma involving the mandible: A case report and descriptive literature review.
Journal: Experimental and therapeutic medicine
Published: October 27, 2023
METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC.
Journal: Oral diseases
Published: August 21, 2023
Application of delayed extubation for the free-flap reconstruction of oral and maxillofacial defects in patient with oral diseases.
Journal: Journal of stomatology, oral and maxillofacial surgery
Published: April 17, 2023
SOD2 confers anlotinib resistance via regulation of mitochondrial damage in OSCC.
Journal: Oral diseases
Published: July 06, 2022
Last Updated: 09/26/2026